Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Randomized phase II trial to compare the effectiveness of two different regimens of Ro 31-7453 in treating patients who have recurrent or refractory metastatic colorectal cancer.

Timeline

Start

2000-12

Primary completion

2002-06

Completion

2002-06

Drugs

Indications